Changes in late auditory evoked potentials induced by corticotropin-releasing hormone and corticotropin fragment 4-9 in male controls

Neuropsychobiology

Volumn 33, Issue 2, 1996, Pages 90-96

  Hartmann, Andreas ^a   Krumrey, Klaus ^a   Vogl, Luise ^a   Dirlich, Gerhard ^a   Holsboer, Florian ^a   Heuser Link, Marcus ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Adrenocorticotropic hormone 4 9; Auditory evoked potentials; Brain electric source analysis; Corticotropin releasing hormone; Hypothalamic pituitary adrenocortic system

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN[4-9]; HYDROCORTISONE; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; EVOKED AUDITORY RESPONSE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; CORTICOTROPIN-RELEASING HORMONE; EVOKED POTENTIALS, AUDITORY; HUMANS; MALE; REACTION TIME;

EID: 0029987017     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119256     Document Type: Article

References (32)

1. Holsbocr F, Spengler D, Heuser I: The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia, Prog Brain Res 1992:93:385-417.
2. De Souza EB: Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution, J Ncu-rosci 1987:7:88-100.
3. Owens MJ, Nemerof TCB: Physiology and pharmacology of corticotropin-releasing factor, Pharmacol Rev 1991:43:425-473.
4. Koob GF, Bloom FE: Corticotropin-releasing factor and behavior, Fed Proc 1985:44:259-263.
5. Dunn AJ, Bcrridgc CW: Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990;15:71-100.
6. De Wied D, Jolles J: Neuropeptides derived from pro-opiocortin: Behavioral, psychological and neurochemical effects, Physiol Rev 1982: 62:976-1056.
7. Hock FM, Gerhards HJ, Wiemer G, Usinger P, Geiger R: Learning and memory processes of an ACTH (4-9) analog (Ebiratide: Hoe 427) in mice and rats, Peptides 1988;9:575-581.
8. Heuser I, Hcuscr-Link M, Gotthardt U, Gras-ser A, Holsbocr F: Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease, J Clin Psychopharmacol 1993:13:171-174.
9. Holsbocr F, von Bardeleben U, Steiger A: Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man, Neuroendocrinology 1988;48:32-38.
10. Steiger A, Guldner J, Knisatschek H, Rothe B, Lauer C, Holsbocr F: Effects of an ACTH/ MSH (4-9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans, Peptides 1991;12:1007-1010.
11. Bom J, Seidel E, Pietrowsky R, Fehrn FIL: Brain-evoked responses, a bioassay for central actions of adrenocorticotropin (ACTH 1-39) and corticotropin-releasing hormone (CRH) in humans, Horm Mctab Res 1991:23:126-130.
12. Donchin E: Event-related potentials: A tool in the study of human information processing; in Begleiter H (ed): Evoked Brain Potentials and Behavior, New York, Plenum Press, 1979, pp 13-88.
13. Kutas M, Hillyard SA: Event-related potentials in cognitive science; in Gazzaniga MS (ed): Handbook of Cognitive Neuroscience, New York, Plenum Press, 1984, pp 387-409.
14. Rockslroh B, Elbert T, Lutzcnberger W, Birn-baumer N, Fchm HL, Voigt KH: Effect of an ACTH 4-9 analog on human cortical evoked potentials in a constant foreperiod reaction time paradigm, Psychoneuroendocrinologv 1981:6:301-310.
15. Rockstroh B, Elbert T, Lutzcnberger W, Birn-baumer N, Voigt, KH, Fehrn H: Distractability under the influence of an ACTH 4-9 derivate, Int J Neurosci 1983;22:21-36.
16. Fehrn HL, Bom J: Effects of corticotropin-releasing hormone on human brain function: An analysis based on auditory evoked potentials, Horm Metab Res 1987(suppl 87):75-79.
17. Bom J, Fehm-Wolfsdorf G, Schiebc M, Rockstroh B, Fehrn HL, Voigt KH: Dishabituating effects of an ACTH 4-9 analog in a vigilance task, Pharmacol Biochetn Behav 1984:21:513-519.
18. Bom J, Kern W, Pietrowsky R, Sittig W, Fehrn HL: Fragments of ACTH affect clectrophysio-logical signs of controlled stimulus processing in humans, Psychopharmacology (Beri) 1989; 99:439-444.
19. Bom J, Bathcll B, Pietrowsky R, Pauschingcr P, Fchm HL: Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin-releasing hormone (h-CRH) on human auditory evoked potentials, Psychopharmacology (Beri) 1990;101:34-38.
20. Wiemer G, Gerhards HJ, Hock FJ, Usinger P, von Rechcnberg W, Geiger R: Neurochemical effects of the synthetic ACTH (4-9) analog HOE 427 in rat brain, Peptides 1988;9:1081-1087.
21. Gratton G, Coles MGH, Donchin E: A new method for off-line removal of ocular artifact, Electroencephalogr Clin Neurophysiol 1983: 55:468-484.
22. Dirlich G, Gerull B, Scherg M, Hcuscr-Link M: A method for the correction of DC drift in continuous EEG recordings for evoked potentials, Electroencephalogr Clin Neurophysiol 1993; 87:26.
23. Scherg M: Brain electric source analysis: The importance of physiological constraints, Brain Topogr 1990:3:268-269.
24. Naiitancn R, Picton T: The N wave of the human electric and magnetic response to sound: A review and an analysis of the component structure, Psychophysiology 1987:24: 375-425.
25. Scherg M, Vajsar J, Picton TW: A source analysis of the late human auditory evoked potentials, J Cogn Neurosci 1989;1:336-355.
26. Naatanen R: The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function, Behav Brain Sci 1990:13: 201-288.
27. Rockstroh B: Consequences of the regulation of cortical excitability as reflected in ERP’s - Evidence for the theory: in Rockstroh B (ed): Slow Cortical Potentials and Behaviour, ed 2, Baltimore, Urban & Schwarzenberg, 1989, pp 159-162.
28. Paavilainen P, Alho K, Reinikainen K, Sams M, Naatanen R: Right-hemispheric dominance of different mismatch negativities, Elcctroencephalogr Clin Ncurophysiol 1991;78:466-479.
29. Nink M, Krause U, Lehnert H, Beyer J: Safety and side effects of human and ovine corticotropin-releasing hormone administration in man, Klin Wochenschr 1991;69:185-195.
30. Grunt M, Glaser J, Schmidhuber H, Pauschingcr P, Bom J: Effects of corticotropin-releasing factor on isolated rat heart activity, Am J Physiol 1993;264:H1124-1129.
31. Partridge WM: Peptide Drug Delivery to the Brain, New York, Raven Press, 1991, pp 1-77.
32. Shimura T, Tabala S, Ohnishi T, Terasaki T, Tsuji A: Transport mechanism of a new behav-iorally highly potent adrenocorticotropic hormone (ACTH) analog, Ebiratide, through the blood-brain barrier, J Pharmacol Exp Ther 1991;258:459-465.